Isolated Coronary Arteritis Treated With FDG-PET/CT-Guided Immunosuppressant to Break the Vicious Cycle of In-Stent Restenosis

Recurrent in-stent restenosis of the coronary artery is a rare but intractable problem. In this situation, coronary arteritis should be considered as an etiology. This case highlights the use of immunosuppressive drugs, including tocilizumab, and follow-up F-18-fluorodeoxyglucose positron emission t...

全面介紹

書目詳細資料
發表在:JACC: Case Reports
Main Authors: Akihiro Takasaki, MD, PhD, Tairo Kurita, MD, PhD, Yumi Hirota, MD, Kenta Uno, MD, Yosuke Kirii, MD, Mizuki Ichikawa, MD, PhD, Masaki Ishiyama, MD, PhD, Mitsuyasu Terashima, MD, PhD, Ayako Nakajima, MD, PhD, Kaoru Dohi, MD, PhD
格式: Article
語言:英语
出版: Elsevier 2023-12-01
主題:
在線閱讀:http://www.sciencedirect.com/science/article/pii/S2666084923004382
實物特徵
總結:Recurrent in-stent restenosis of the coronary artery is a rare but intractable problem. In this situation, coronary arteritis should be considered as an etiology. This case highlights the use of immunosuppressive drugs, including tocilizumab, and follow-up F-18-fluorodeoxyglucose positron emission tomography/computed tomography to break the vicious circle of recurrent stenosis caused by isolated coronary arteritis of unknown cause.
ISSN:2666-0849